Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00990457 · ClinicalTrials.gov registry record · Phase 3
Evaluating the Effects Two Diets Combined With Exercise in Persons With Abdominal Obesity (The SHAPE5 Study)
A Phase 3 study of Overweight and Obese, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 3
- Development phase
- 77
- Enrollment target
- 1
- Study location
NCT00990457 is a Phase 3 study of Overweight and Obese that has completed, run by Johns Hopkins University. The registered enrollment target is 77 participants, below the 1,323-participant average among 197 other Overweight trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00990457, a Phase 3 study of Overweight and Obese, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 77 participants
- Enrollment target
- 1
- Study location
Study Summary
Abdominal obesity, which is affected by a lack of physical activity and excess weight, put people at an increased risk of cardiovascular disease. This study will compare the effects of two different dietary approaches to weight loss, each combined with exercise, for their effects on cardiovascular factors that are early predictors of future cardiovascular disease in overweight and obese people with excessive weight around their waist. The two diets are a low-carbohydrate versus a more traditional low-fat, low calorie diet.
Conditions Studied
Interventions
- BEHAVIORAL Weight Loss Diets Plus Exercise
Study Locations (1)
Maryland
- Johns Hopkins Bayview Medical Center - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2009-10 |
| Est. Completion | 2011-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00990457
The ClinicalTrials.gov registry entry for NCT00990457 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 77 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,323-participant average among 197 other Overweight trials with a reported enrollment target (94% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Overweight appearing as the primary indexed condition, and to 1 intervention - of which Weight Loss Diets Plus Exercise is the first listed.
NCT00990457 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT00990457 about?
NCT00990457 is a clinical study titled "Evaluating the Effects Two Diets Combined With Exercise in Persons With Abdominal Obesity (The SHAPE5 Study)". Abdominal obesity, which is affected by a lack of physical activity and excess weight, put people at an increased risk of cardiovascular disease. This study will compare the effects of two different dietary approaches to weight loss, each combined with exercise, for their effects on cardiovascular f...
What is the current status of trial NCT00990457?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 77 participants. The study started on 2009-10. Estimated completion is 2011-09.
What conditions does trial NCT00990457 study?
This clinical trial studies the following conditions: Overweight, Obese, Sedentary, Abdominal Obesity.
What interventions are being tested in trial NCT00990457?
The interventions under investigation include: Weight Loss Diets Plus Exercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT00990457?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00990457 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Overweight
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
RECRUITING · Phase 3
-
A Study of Retatrutide (LY3437943) in Participants With Obesity or Overweight
RECRUITING · Phase 3
-
A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight With and Without Type 2 Diabetes
RECRUITING · Phase 3
-
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
RECRUITING · Phase 3
-
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and at Least One Weight-Related Comorbidity
RECRUITING · Phase 3
-
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.